Login / Signup
Discovery of Novel Alpha-Amylase Inhibitors for Type II Diabetes Mellitus Through the Fragment-Based Drug Design.
Yulianti
Agustinus Corona Boraelis Kantale
Usman Sumo Friend Tambunan
Published in:
IWBBIO (1) (2019)
Keyphrases
</>
type ii
diabetes mellitus
drug design
protein protein interactions
type i error
diabetic patients
protein structure prediction
data mining
knowledge discovery
quantitative structure activity
drug discovery
network topology
discovery process
high throughput
high precision
systems biology
machine learning